Automated Tumor Immunophenotyping Predicts Clinical Benefit from Anti-Pd-l1 Immunotherapy

Xiao Li,Jeffrey Eastham,Jennifer M. Giltnane,Wei Zou,Andries Zijlstra,Evgeniy Tabatsky,Romain Banchereau,Ching-Wei Chang,Barzin Y. Nabet,Namrata S. Patil,Luciana Molinero, Steve Chui, Maureen Harryman,Shari Lau,Linda Rangell,Yannick Waumans,Mark Kockx,Darya Orlova,Hartmut Koeppen

JOURNAL OF PATHOLOGY（2024）

Cited 0|Views25

No score

Key words

immunophenotype,panCK/CD8 immunohistochemistry,CD8+T cell,non-small cell lung cancer,triple-negative breast cancer,artificial intelligence,anti-PD-L1 immunotherapy,survival analysis

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined